Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Alsina

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Multiple myeloma: increasing our treatment optionsMelissa Alsina
Cancer Control : Journal of the Moffitt Cancer Center|October 7, 2011
Advances in the autologous and allogeneic transplantation strategies for multiple myelomaTaiga Nishihori, Melissa Alsina
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Farnesyltransferase inhibitors and their role in the treatment of multiple myelomaRodrigo Santucci, Paul A Mackley, Saïd Sebti, et al.
Seminars in Hematology|June 11, 2004
Targeting the bone marrow microenvironment in hematologic malignanciesWilliam S Dalton, Lori Hazlehurst, Kenneth Shain, et al.
Case Reports in Transplantation|December 22, 2012
Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?Diógenes Alayón-Laguer, Melissa Alsina, Jose L Ochoa-Bayona, et al.
British Journal of Haematology|May 28, 2008
HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myelomaRamadevi Nimmanapalli, Elvira Gerbino, William S Dalton, et al.
Immunotherapy|September 4, 2013
Immunotherapy strategies for multiple myeloma: the present and the futureFrederick L Locke, Taiga Nishihori, Melissa Alsina, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2018
Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic EntityFernando Javier Bonilla-Valentín, Javier Cerra, William Cáceres-Perkins, et al.
Future Oncology (London, England)|March 18, 2025
Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtableMelissa Alsina, Binod Dhakal, Jeremy Pantin, et al.
Blood|December 13, 2003
Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell linesYulia Nefedova, Pingyan Cheng, Melissa Alsina, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Multiple myeloma: increasing our treatment optionsMelissa Alsina
Cancer Control : Journal of the Moffitt Cancer Center|October 7, 2011
Advances in the autologous and allogeneic transplantation strategies for multiple myelomaTaiga Nishihori, Melissa Alsina
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Farnesyltransferase inhibitors and their role in the treatment of multiple myelomaRodrigo Santucci, Paul A Mackley, Saïd Sebti, et al.
Seminars in Hematology|June 11, 2004
Targeting the bone marrow microenvironment in hematologic malignanciesWilliam S Dalton, Lori Hazlehurst, Kenneth Shain, et al.
Case Reports in Transplantation|December 22, 2012
Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?Diógenes Alayón-Laguer, Melissa Alsina, Jose L Ochoa-Bayona, et al.
British Journal of Haematology|May 28, 2008
HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myelomaRamadevi Nimmanapalli, Elvira Gerbino, William S Dalton, et al.
Immunotherapy|September 4, 2013
Immunotherapy strategies for multiple myeloma: the present and the futureFrederick L Locke, Taiga Nishihori, Melissa Alsina, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2018
Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic EntityFernando Javier Bonilla-Valentín, Javier Cerra, William Cáceres-Perkins, et al.
Future Oncology (London, England)|March 18, 2025
Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtableMelissa Alsina, Binod Dhakal, Jeremy Pantin, et al.
Blood|December 13, 2003
Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell linesYulia Nefedova, Pingyan Cheng, Melissa Alsina, et al.
Pageof 13